1-Phenyl-1,3,8-triazaspiro[4.5]decan-4-one
CAS : 1021-25-6
Ref. 3D-FP156010
1g | Arrêté | ||
2g | Arrêté | ||
5g | Arrêté | ||
10g | Arrêté | ||
250mg | Arrêté | ||
500mg | Arrêté |
Informations sur le produit
- 1,3,8-Triazaspiro[4.5]decan-4-one, 1-phenyl-
- 1-Phenyl-1,3,8-Triaza-Spiro[4.5]Decan-4-One
- 1-Phenyl-1,3,8-Triazaspiro(4,5)Decan-4-One
- 1-Phenyl-4-oxo-1,3,8-triazaspiro[4.5]decane
- 4-Oxo-1-Phenyl-1,3-Diaza-8-Azoniaspiro[4.5]Decane
- 4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]decane
- NSC 96918
- 1-phenyl-1,3,8-triazaspiro(4.5)decan-4-one
1-Phenyl-1,3,8-triazaspiro[4.5]decan-4-one is a drug that binds to the benzodiazepine receptor, which is located in the central nervous system. It does not bind to any other receptors and is therefore selective for benzodiazepines. 1-Phenyl-1,3,8-triazaspiro[4.5]decan-4-one has been shown to be effective at doses of 5mg/kg in animals and is metabolized by hydroxylation. This drug has been shown to have effects on the central nervous system and can cause an increase in cholinergic activity or a decrease in dopamine levels.